Rather than isolating the user in a virtual world, mixed reality allows contextualized data to be shared in real time, improving assays, standard operating procedures, workflows, and overall tech transfer.
Augmented or mixed reality offers benefits in tech transfer, general batch recordkeeping and SOPs, and training, especially the transmission of “tribal knowledge” that cannot be put in a training manual. Now that augmented reality hardware has sufficiently advanced, use of the technology is starting to take off in pharma. Apprentice.io is focusing on pharma and biotech applications. The company’s CEO and cofounder Anthony Stracquatanio discusses trends.
Read this article in Pharmaceutical Technology's Bio/Pharma Laboratory Best Practices 2018 eBook.
Pharmaceutical Technology
eBook: Bio/Pharma Laboratory Best Practices 2018
Vol. 42
November 2018
Pages: 8–9
When referring to this article, please cite it as A. Shanley, "Mixed Reality Gains a Foothold in the Lab," Pharmaceutical Technology Bio/Pharma Laboratory Best Practices eBook (November 2018).
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.